Your browser is no longer supported. Please, upgrade your browser.
Settings
AKTX Akari Therapeutics, Plc daily Stock Chart
AKTX [NASD]
Akari Therapeutics, Plc
Index- P/E- EPS (ttm)-2.36 Insider Own20.51% Shs Outstand12.41M Perf Week5.47%
Market Cap62.17M Forward P/E- EPS next Y-4.61 Insider Trans0.00% Shs Float3.40M Perf Month-24.21%
Income-27.70M PEG- EPS next Q-0.64 Inst Own29.10% Short Float0.65% Perf Quarter-23.16%
Sales- P/S- EPS this Y71.00% Inst Trans-13.92% Short Ratio0.03 Perf Half Y-31.37%
Book/sh1.90 P/B2.64 EPS next Y-52.10% ROA-57.80% Target Price6.00 Perf Year-67.68%
Cash/sh2.81 P/C1.78 EPS next 5Y- ROE-80.30% 52W Range4.11 - 22.20 Perf YTD-28.84%
Dividend- P/FCF- EPS past 5Y38.70% ROI- 52W High-77.12% Beta-8.77
Dividend %- Quick Ratio2.60 Sales past 5Y- Gross Margin- 52W Low23.60% ATR0.62
Employees15 Current Ratio2.60 Sales Q/Q- Oper. Margin- RSI (14)33.47 Volatility14.15% 12.22%
OptionableNo Debt/Eq0.00 EPS Q/Q-322.50% Profit Margin- Rel Volume0.06 Prev Close5.01
ShortableYes LT Debt/Eq0.00 EarningsJun 08 Payout- Avg Volume754.58K Price5.08
Recom2.30 SMA20-3.84% SMA50-44.49% SMA200-41.26% Volume38,866 Change1.40%
May-31-17Upgrade Chardan Capital Markets Sell → Neutral $6
Apr-17-17Reiterated Chardan Capital Markets Sell $6.50 → $5
Jul-11-16Initiated Chardan Capital Markets Sell $5
Jun-26-17 04:43PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm Accesswire
10:36AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-23-17 11:59PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm Accesswire +8.18%
04:48PM  Akari Notice: Rosen Law Firm Reminds Akari Therapeutics, Plc Investors of Important Deadline in Class Action - AKTX GlobeNewswire
07:00AM  Akari Therapeutics to Present Data from Phase 2 PNH Trial of Coversin at the 22nd Congress of the European Hematology Association GlobeNewswire
Jun-22-17 02:16PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire -5.17%
10:34AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-21-17 05:28PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire +5.89%
10:36AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) and Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-20-17 01:48PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire +5.56%
Jun-19-17 05:59PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm Business Wire -5.86%
03:36PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire
10:35AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-16-17 10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Akari Therapeutics, Plc (AKTX) Business Wire +14.90%
Jun-15-17 04:36PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire -10.92%
10:32AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-14-17 04:11PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm Accesswire
01:00PM  URGENT: Monteverde & Associates PC Reminds Shareholders of Class Action Against Akari Therapeutics, Plc - AKTX & July 11th, 2017 Lead Plaintiff Deadline Accesswire
Jun-13-17 10:42AM  INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-12-17 11:45AM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm GlobeNewswire -6.43%
10:35AM  INVESTOR ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017 Accesswire
Jun-09-17 11:00PM  URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Losses to Contact the Firm Immediately - AKTX Accesswire -5.37%
Jun-08-17 02:38PM  EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 GlobeNewswire
Jun-07-17 04:11PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Akari Therapeutics, Plc (Nasdaq: AKTX) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire -5.18%
Jun-06-17 06:38PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm GlobeNewswire
05:47PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX GlobeNewswire
Jun-02-17 11:54PM  EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire +7.87%
10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc - (AKTX) PR Newswire
12:13PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Akari Therapeutics, Plc to Contact the Firm Accesswire
10:31AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 Accesswire
Jun-01-17 05:19PM  SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
02:54PM  URGENT: Monteverde & Associates PC Invites Akari Therapeutics, Plc. Shareholders with Significant Losses To Contact The Firm Immediately - AKTX PR Newswire
May-31-17 08:38PM  INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
09:54AM  Biotech Movers: Akari, Array, Amicus TheStreet.com
May-30-17 07:40PM  [$$] Akari Therapeutics CEO Resigns The Wall Street Journal -10.89%
06:02PM  Akari Therapeutics Announces Resignation of CEO Business Wire
01:43PM  Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, Inc., Amgen Inc., Cel-Sci Corp., Dick's Sporting Goods, Inc., Eco Science Solutions, Inc., Intra-Cellular Therapies, Inc. and Twilio Inc. PR Newswire
May-25-17 02:37PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm GlobeNewswire
10:10AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 GlobeNewswire
May-23-17 04:53PM  SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm GlobeNewswire -6.15%
04:45PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akari Therapeutics, Plc to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
04:32PM  AKTX LOSS NOTICE: Rosen Law Firm Reminds Akari Therapeutics, Plc Investors of Important Deadline in Class Action - AKTX Business Wire
12:37PM  Investor Alert: Kaplan Fox Announces Investigation Of Akari Therapeutics, PLC PR Newswire
12:24PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc Accesswire
May-22-17 07:40PM  IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm PR Newswire +5.09%
05:56PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm PR Newswire
08:52AM  Amgen Evenity Approval Derailed on Cardiovascular Side Effect Zacks
May-20-17 01:39PM  IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Accesswire
May-19-17 10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc - (AKTX) Marketwired
03:24PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm PR Newswire
02:22PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Announces the Filing of a Class Action against Akari Therapeutics plc and Certain Officers AKTX GlobeNewswire
May-18-17 01:46PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm PR Newswire
01:20PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline: July 11, 2017 PR Newswire
08:38AM  What Falling Estimates & Price Mean for AveXis, Inc. (AVXS) Zacks
08:30AM  BioDelivery Sciences International (BDSI) Jumps: Stock Up 5% Zacks
May-17-17 10:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Akari Therapeutics, Plc Accesswire
May-16-17 03:31PM  Why Is Vertex Pharma (VRTX) Stock Soaring This Year? Zacks -11.42%
May-15-17 09:46PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Akari Therapeutics, Plc and Advises Investors With Losses to Contact the Firm Business Wire
08:00PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akari Therapeutics, Plc (Nasdaq: AKTX) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
05:13PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Business Wire
02:12PM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akari Therapeutics, Plc Investors and Encourages Investors to Contact the Firm Business Wire
01:33PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Business Wire
12:31PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc - AKTX Business Wire
12:09PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc Accesswire
11:25AM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Akari Therapeutics, Plc GlobeNewswire
10:45AM  INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Business Wire
10:38AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akari Therapeutics plc - AKTX Accesswire
08:45AM  Geron Corp (GERN) Worth a Look: Stock Adds 7% in Session Zacks
May-14-17 08:50PM  AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc (AKTX) GlobeNewswire
May-13-17 12:07AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Encourages Investors with Losses to Contact the Firm Business Wire
May-12-17 11:34PM  AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm GlobeNewswire -21.41%
09:47PM  [$$] Overheard The Wall Street Journal
07:49PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Akari Therapeutics, Plc and Encourages Investors With Losses to Contact the Firm Business Wire
06:07PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akari Therapeutics Plc (AKTX) PR Newswire
05:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akari Therapeutics plc - AKTX PR Newswire
04:32PM  SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Business Wire
04:18PM  AKARI INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akari Therapeutics, Plc To Contact The Firm Business Wire
03:42PM  Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Akari Therapeutics, Plc Business Wire
02:37PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Akari Therapeutics, Plc and Advises Investors with Losses to Contact the Firm Business Wire
01:25PM  AKARI INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akari Therapeutics, Plc To Contact The Firm PR Newswire
12:52PM  Akari Therapeutics: Another Biotech Wonder The Wall Street Journal
12:41PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Akari Therapeutics, Plc Business Wire
11:52AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Akari Therapeutics, Plc Investors Business Wire
11:36AM  INVESTOR ALERT: Investigation of Akari Therapeutics Announced by Holzer & Holzer Business Wire
10:19AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Akari Therapeutics Business Wire
May-11-17 07:09PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Akari Therapeutics PLC Investors Business Wire
08:44AM  Puma (PBYI) Q1 Loss Narrows, Focus Remains on Neratinib Zacks
May-10-17 10:30AM  Celldex (CLDX) Q1 Loss In Line, Revenues Beat, Shares Up Zacks
08:15AM  Geron (GERN) Q1 Loss In Line, Focus Remains on Imetelstat Zacks
May-04-17 10:27AM  Clovis (CLVS) Q1 Loss Narrows, Rubraca Off to a Good Start Zacks
Apr-27-17 06:47AM  Akari Therapeutics Announces Edisons Withdrawal of Edison Report titled Akaris Coversin matches Soliris in Phase II GlobeNewswire -8.87%
Apr-24-17 12:33PM  Is This Why Akari Therapetuics PLC Is Falling Today? Motley Fool -14.68%
07:25AM  Akari Therapeutics stock rises 10% on positive mid-stage trial results MarketWatch
07:15AM  Akari Therapeutics Demonstrates Positive Response with Coversin in Ongoing Phase 2 PNH Trial and in Additional Clinical Targets GlobeNewswire
Apr-21-17 05:31AM  Akari Therapeutics (AKTX) Shares March Higher, Can It Continue? Zacks +25.23%
Apr-19-17 03:36PM  Harry Boxers momentum stocks to watch: 3 biotechs, 1 retailer MarketWatch -7.88%
Apr-03-17 10:22AM  Company News for April 03, 2017 Zacks +5.78%
09:30AM  Akari Therapeutics, Galectin Therapeutics Receive Positive Financial News Accesswire
07:00AM  Akari Therapeutics to Present at the Jefferies Complement Symposium GlobeNewswire
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. Its lead drug candidate is Coversin, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barre syndrome, and atypical hemolytic uremic syndrome. The company is based in New York, New York. Akari Therapeutics, Plc is a subsidiary of RPC Pharma Limited.